Stay updated on Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial

Sign up to get notified when there's something new on the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.0 to v3.5.2.
    Difference
    0.2%
    Check dated 2026-04-17T02:33:30.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The new screenshot shows updates to the page layout and navigation elements. There are no changes to the core study data (eligibility criteria, endpoints, or study descriptions).
    Difference
    0.1%
    Check dated 2026-04-09T21:31:59.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    No substantive content changes detected; the two screenshots show the same study details and page structure. Any observed differences appear to be visual/UI adjustments only.
    Difference
    0.1%
    Check dated 2026-04-02T15:23:55.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    No additions or deletions were detected between the two screenshots; the page content and structure appear unchanged.
    Difference
    0.1%
    Check dated 2026-03-26T11:24:15.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Site revision updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T05:13:00.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.2%
    Check dated 2026-03-12T01:15:47.000Z thumbnail image

Stay in the know with updates to Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page.